SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-300008
Filing Date
2023-12-20
Accepted
2023-12-20 16:58:01
Documents
12
Period of Report
2023-12-19
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d676863d8k.htm   iXBRL 8-K 24786
  Complete submission text file 0001193125-23-300008.txt   150966

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA akli-20231219.xsd EX-101.SCH 2879
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE akli-20231219_lab.xml EX-101.LAB 18739
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE akli-20231219_pre.xml EX-101.PRE 11727
6 EXTRACTED XBRL INSTANCE DOCUMENT d676863d8k_htm.xml XML 3508
Mailing Address 71 COMMERCIAL STREET MAILBOX 312 BOSTON MA 02109
Business Address 71 COMMERCIAL STREET MAILBOX 312 BOSTON MA 02109 617-456-0597
Akili, Inc. (Filer) CIK: 0001850266 (see all company filings)

IRS No.: 923654772 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40558 | Film No.: 231501978
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)